Skip to content
DataLookout
Menu

NCT06666751

Anterior Segment Optical Coherence Tomography Microstent Positioning

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 2 words Show 4 more changesShow less
    • Trial completed
    • Final enrollment: 79 participants (planned 116)
    • Primary completion date changed from estimate of Apr 30, 2027 to Oct 16, 2025
    • Secondary endpoints: 6 to 5
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Difference in percentage of mispositioned stents between Hydrus microstent and iStent groups
Timeframe: Two years post stent placement

Secondary (5)

Dilation of Schlemm's canal
Change in IOP from baseline
Reduction in number of IOP lowering medications
Percentage of patients needing additional glaucoma surgery
Proportion of stent cases with proper placement via anterior segment OCT versus proportion of cases with proper placement via intraoperative gonioscopy

Arms and interventions

Hydrus microstent

Participants in this group underwent Hydrus microstent placement at the Moran Eye Center.

iStent Inject

Participants in this group underwent iStent Inject placement at the Moran Eye Center.

Procedures: Cataract plus Microstent surgery

Sites

1 site in 1 country

  • Moran Eye CenterMurray, Utah, United States